Aegion Corporation AEGN reported lower-than-expected fourth-quarter 2019 results, wherein the top and bottom lines missed the respective Zacks Consensus Estimate mainly due to lower revenues across segments.Adjusted earnings per share of 39 cents lagged the consensus mark of 40
Sabre Corporation SABR reported fourth-quarter 2019 adjusted earnings per share of 16 cents, which declined 52.9% on a year-over-year basis. Moreover, the bottom line lagged the Zacks Consensus Estimate by 5.88%.Revenues came in at $941.4 million, up 1.9% from the year-ago quart
Value investing is gaining popularity by the day. The success of value investors like Warren Buffett further underscores this. Buffett and his business partner, Charlie Munger, managed to register 20.3% compound annual growth in the market value of Berkshire Hathaway from 1965 t
One stock that might be an intriguing choice for investors right now is ResMed Inc. RMD. This is because this security in the Medical - Products space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
Gilead Sciences, Inc. GILD was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trad
Chico's FAS (CHS) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items.
Intellia Therapeutics, Inc. (NTLA) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to loss of $0.43 per share a year ago. These figures are adjusted for non-recurring items.
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse